
News|Videos|March 5, 2026
Expert panel: Navigating shifts in maternal immunization guidance
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Benjamin P. Saylor
An expert infectious disease panel discusses how recent federal vaccine schedule changes can impact maternal immunizations and potential repercussions.
Advertisement
Advertisement
As the healthcare community adjusts to several federal vaccine recommendation changes from the CDC’s Advisory Committee on Immunization Practices (ACIP), many professionals have expressed frustration and confusion. Changes—including the move to “shared clinical decision-making” and the re-categorization of certain vaccines—have sent ripples through the industry, leading some providers to prioritize long-standing medical society recommendations over shifting federal guidance.
Related to this article

The United States earned a D+ for preterm birth for the fifth straight year, with a 10.4% preterm birth rate in 2025.

Kristin Macgregor, PhD, on why perinatal depression goes unspoken and how screening and integrated behavioral health can close the care gap.

"The loss of... measles elimination status represents a significant public health setback," said ACOG President Camille A. Clare, MD.

Patients with 3 or more adverse pregnancy outcomes had lower odds of postpartum contraceptive use in a PRAMS analysis of 222,412 individuals.

Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.

Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.

Experts explain how puberty affects lipid levels, body composition, and mental health, with implications for cardiovascular screening in adolescent girls.
Advertisement
Advertisement
